AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05211570 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia Refractory
Acute Myeloid Leukemia, in Relapse
Myelodysplastic Syndrome Acute Myeloid Leukemia

Interventions

DRUG: AB8939
DRUG: Venetoclax

Sponsor

AB Science